i-sep.com
Get leads like I-sep — and thousands more
Build targeted lists by tech stack, traffic, and more
i-SEP: The Quiet Giant in Blood Management
A Nantes-based Medtech is solving a $30B problem with one elegant piece of hardware
While AI and digital health dominate headlines, i-SEP is tackling a visceral, high-stakes problem: the $30B global blood transfusion market. Based in Nantes, France, this 45-person team is building the alternative to allogeneic blood transfusions with patented intraoperative cell salvage technology.
"i-SEP isn't just another Medtech startup—they're building the infrastructure for a world where blood is a renewable resource, not a scarce commodity."
The Silent Scarcity Crisis
The blood shortage crisis isn't coming—it's already here. i-SEP's core thesis is that the current model of allogeneic blood transfusions is unsustainable: expensive, risky, and increasingly scarce. Their technology allows surgeons to recover and reinfuse a patient's own blood during surgery, reducing reliance on donor blood by up to 60%. With only 331 monthly visits, i-SEP is flying under the radar, but their clinical impact is measurable.
The Growth Engine
Despite modest traffic, i-SEP's keyword strategy reveals intent. They rank for 'cell saver' (3,220 monthly searches) and 'cell saver machine' (440 searches)—high-intent, clinical terms. This isn't vanity traffic; it's surgeons and hospital procurement teams searching for solutions. Their 45% organic traffic share suggests a lean, efficient inbound strategy focused on clinical credibility over mass marketing.
The company's leadership team is uniquely qualified for this challenge. Patricia Villegas, Director of Scientific, Regulatory Affairs & Quality, navigates the complex FDA/EMA pathways. Thibault Cretinon leads R&D and production, while Mallorie Dépond drives the biochemistry behind the separation technology. This isn't a team of generalists—they're specialists in blood.
- Patented blood separation technology for intraoperative use
- Patient Blood Management (PBM) focus—reducing transfusion risks
- 45-person team with deep clinical and regulatory expertise
- Revenue of $5M with no disclosed funding—likely bootstrapped or strategic
- Strong LinkedIn presence for B2B Medtech credibility
The Verdict: A Sleeping Giant in Medtech
i-SEP is building infrastructure, not hype. In a world of flashy AI startups, this is a company solving a real, urgent problem with precision engineering and clinical rigor. For investors and founders, the lesson is clear: sometimes the most valuable companies are the ones no one is talking about.
What tech stack does I-sep use?
How much traffic does I-sep get?
Traffic & Engagement
Traffic Sources
Where is I-sep's audience located?
What keywords does I-sep rank for?
5 keywordsHow is I-sep's SEO?
Open Graph Image
https://www.i-sep.com/wp-content/uploads/2024/05/1b7a0731-1-1024x683.jpg
Meta Tags
i-SEP - the alternative to allogeneic blood transfusions
i-SEP is a French Medtech, based in Nantes (Upper Brittany, France) specialized in intraoperative cell salvage (IOCS) and Patient Blood Management (PBM) .i-SEP has developed and patented an innovative technology for the separation of blood components.
H1 Tags
Schema Types
What is I-sep's revenue?
Who works at I-sep?
Loading leads...
What do customers think of I-sep?
No Trustpilot reviews available for this company.
Frequently Asked Questions about I-sep
What is I-sep's Revenue?
What does I-sep do?
How fast is I-sep growing?
What technologies does I-sep use?
Who are I-sep's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact I-sep?
Social Profiles
Contact Information
Export i-sep.com Data
Download the complete tech stack, analytics, leads, and company data for i-sep.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About i-sep.com
i-SEP is a French Medtech, based in Nantes (Upper Brittany, France) specialized in intraoperative cell salvage (IOCS) and Patient Blood Management (PBM) .i-SEP has developed and patented an innovative technology for the separation of blood components.
Company Overview
i-sep.com Social Media
Contact i-sep.com
Email Addresses
Phone Numbers
Technology Stack
i-sep.com uses 15 technologies across their website including Vimeo, reCAPTCHA, PHP, and more.
Video
Vimeo
Security
reCAPTCHA
Programming Languages
PHP
CMS
WordPress
Analytics & Marketing
Google Tag Manager, Google Analytics
Performance
Lazy Loading
Traffic & Audience
i-sep.com receives approximately 331 monthly visitors. The website has a bounce rate of 34% with visitors viewing an average of 4.5 pages per visit. Users spend an average of 2:33 on the site.
The majority of i-sep.com's traffic comes from undefined, undefined, .
Frequently Asked Questions
What is i-sep.com?
What technologies does i-sep.com use?
How do I contact i-sep.com?
What are i-sep.com's social media accounts?
Is i-sep.com hiring?
How popular is i-sep.com?
Related Searches
This page provides publicly available information about i-sep.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit i-sep.com directly at https://i-sep.com.